Unlocking the Power of Benchmarking: Real-World-Time Data Analysis for Enhanced Sarcoma Patient Outcomes

Abstract

Benchmarking is crucial for healthcare providers to enhance quality and efficiency, notably for complex conditions like sarcomas. Multidisciplinary teams/sarcoma boards (MDT/SBs) are vital in sarcoma management, but differences in their processes can affect patient outcomes and treatment costs, despite adherence to international guidelines. To address this issue, this study aimed to compare two MDT/SBs and establish an interoperable digital platform, Sarconnector®, for real-time-world data assessment and automated analysis. The study included 983 patients, 46.0% of whom female, with a median age of 58 years, and 4.5% of patients presented with metastasis at diagnosis. Differences were observed in the number of first-time presentations, follow-up presentations, primary sarcomas, biopsies and chemotherapy indications between the two MDT/SB. The results highlight the importance of benchmarking and utilizing a harmonized data approach, such as the RWT approach provided by the Sarconnector®, to standardize and evaluate quality and cost metrics. By identifying areas of improvement and making data-driven decisions on the meta-level, healthcare providers can optimize resources and improve patient outcomes. In conclusion, benchmarking with the RWT harmonized data approach provided by the Sarconnector® can help healthcare providers improve the overall effectiveness of the healthcare system and achieve better outcomes for their patients in terms of both outcomes and costs.

Exploring Risk Factors for Predicting 30-Day Postoperative Morbidity in Musculoskeletal Tumor Surgery

“…This study was designed to encompass the broad spectrum of musculoskeletal tumor surgeries, ranging from minor excisions to major resections across various anatomical locations, including both benign and malignant lesions. This comprehensive approach reflects the clinical reality surgeons face in orthopedic oncology, thereby enhancing the relevance and applicability of our findings to diverse healthcare settings [3].…”

“…This study also underscores the impact of multiple erythrocyte transfusions on increasing morbidity, emphasizing the need for meticulous blood management and surgical planning. These findings advocate for the implementation of specialized risk management strategies, aiming to refine surgical interventions and enhance patient outcomes in the complex landscape of musculoskeletal tumor surgery [3,7,14].…”

“…This study included a consecutive cohort of patients from a real-world-time data warehouse who underwent surgical procedures for all musculoskeletal tumors presented at a tertiary referral institution over a four-year period (9 January 2018 to 11 April 2022) [3]. The cohort included patients with both soft tissue and bone tumors, encompassing the entire spectrum from benign and intermediate to malignant tumors and sarcomas.…”

“…Benchmarking has emerged as a vital practice in healthcare to evaluate and improve patient outcomes [3][4][5]. By comparing practices and outcomes across institutions or between disciplines, benchmarking helps establish best practices and set standards of care, particularly in high-stakes fields like sarcoma surgery [6,7].…”

Assessment Scales in Cerebral Palsy: A Comprehensive Review of Tools and Applications

“…Healthcare providers can benchmark an individual's performance against established norms and reference data, facilitating a better understanding of their strengths and areas requiring intervention. Additionally, researchers can analyze and aggregate data from diverse populations, enhancing our collective knowledge of CP [ 25 ].…”